Tectonic Therapeutic Inc/$TECX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tectonic Therapeutic Inc
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Ticker
$TECX
Sector
Primary listing
Employees
60
Headquarters
Website
TECX Metrics
BasicAdvanced
$608M
-
-$4.05
-
-
Price and volume
Market cap
$608M
52-week high
$36.03
52-week low
$13.70
Average daily volume
541K
Financial strength
Current ratio
26.625
Quick ratio
26.257
Long term debt to equity
0.017
Total debt to equity
0.508
Interest coverage (TTM)
-1,333.90%
Profitability
EBITDA (TTM)
-82.661
Effective tax rate (TTM)
-1.69%
Management effectiveness
Return on assets (TTM)
-25.38%
Return on equity (TTM)
-37.82%
Valuation
Price to book
2.42
Price to tangible book (TTM)
2.42
Price to free cash flow (TTM)
-9.847
Free cash flow yield (TTM)
-10.16%
Free cash flow per share (TTM)
-3.29
Growth
Earnings per share change (TTM)
-40.74%
3-year earnings per share growth (CAGR)
-31.77%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tectonic Therapeutic Inc stock?
Tectonic Therapeutic Inc (TECX) has a market cap of $608M as of March 17, 2026.
What is the P/E ratio for Tectonic Therapeutic Inc stock?
The price to earnings (P/E) ratio for Tectonic Therapeutic Inc (TECX) stock is 0 as of March 17, 2026.
Does Tectonic Therapeutic Inc stock pay dividends?
No, Tectonic Therapeutic Inc (TECX) stock does not pay dividends to its shareholders as of March 17, 2026.
When is the next Tectonic Therapeutic Inc dividend payment date?
Tectonic Therapeutic Inc (TECX) stock does not pay dividends to its shareholders.
What is the beta indicator for Tectonic Therapeutic Inc?
Tectonic Therapeutic Inc (TECX) does not currently have a Beta indicator.